IBDEI14Y ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20343,0)
 ;;=054.11^^131^1287^38
 ;;^UTILITY(U,$J,358.3,20343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20343,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,20343,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,20343,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,20344,0)
 ;;=053.9^^131^1287^36
 ;;^UTILITY(U,$J,358.3,20344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20344,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,20344,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,20344,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,20345,0)
 ;;=487.1^^131^1287^39
 ;;^UTILITY(U,$J,358.3,20345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20345,1,4,0)
 ;;=4^487.1
 ;;^UTILITY(U,$J,358.3,20345,1,5,0)
 ;;=5^Influenza
 ;;^UTILITY(U,$J,358.3,20345,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,20346,0)
 ;;=487.0^^131^1287^40
 ;;^UTILITY(U,$J,358.3,20346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20346,1,4,0)
 ;;=4^487.0
 ;;^UTILITY(U,$J,358.3,20346,1,5,0)
 ;;=5^Influenza W/ Pneumonia
 ;;^UTILITY(U,$J,358.3,20346,2)
 ;;=^269942
 ;;^UTILITY(U,$J,358.3,20347,0)
 ;;=386.30^^131^1287^41
 ;;^UTILITY(U,$J,358.3,20347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20347,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,20347,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,20347,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,20348,0)
 ;;=088.81^^131^1287^42
 ;;^UTILITY(U,$J,358.3,20348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20348,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,20348,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,20348,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,20349,0)
 ;;=785.6^^131^1287^43
 ;;^UTILITY(U,$J,358.3,20349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20349,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,20349,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,20349,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,20350,0)
 ;;=031.0^^131^1287^44
 ;;^UTILITY(U,$J,358.3,20350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20350,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,20350,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,20350,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,20351,0)
 ;;=730.00^^131^1287^46
 ;;^UTILITY(U,$J,358.3,20351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20351,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,20351,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,20351,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,20352,0)
 ;;=730.10^^131^1287^47
 ;;^UTILITY(U,$J,358.3,20352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20352,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,20352,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;^UTILITY(U,$J,358.3,20352,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,20353,0)
 ;;=380.10^^131^1287^48
 ;;^UTILITY(U,$J,358.3,20353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20353,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,20353,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,20353,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,20354,0)
 ;;=382.9^^131^1287^49
 ;;^UTILITY(U,$J,358.3,20354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20354,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,20354,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,20354,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,20355,0)
 ;;=614.9^^131^1287^50
 ;;^UTILITY(U,$J,358.3,20355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20355,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,20355,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,20355,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,20356,0)
 ;;=486.^^131^1287^52
 ;;^UTILITY(U,$J,358.3,20356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20356,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,20356,1,5,0)
 ;;=5^Pneumonia
